| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | US7588756 Administering intracoronally a compatible auxiliary or support and a nucleic acid encoding a polypeptide S100A1 protein; increases the systolic Ca2+ release from the sarcoplasmic reticulum and increases the rate of Ca2+ uptake into the sarcoplasmic reticulum |
| 09/15/2009 | CA2439879C C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
| 09/15/2009 | CA2411233C Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 09/15/2009 | CA2409819C Triazole derivatives |
| 09/15/2009 | CA2374902C Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2359463C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2168203C Medicinal for protection from neurological damage |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/11/2009 | WO2009111607A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 09/11/2009 | WO2009111056A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 09/11/2009 | WO2009110782A1 Extract from oil palm leaves comprising phenolic acids |
| 09/11/2009 | WO2009110646A1 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 09/11/2009 | WO2009110526A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 3',5-di-2-propenyl-(1,1'-biphenyl)-2,4'-diol as active ingredient |
| 09/11/2009 | WO2009110468A1 Potassium channel opener |
| 09/11/2009 | WO2009110324A1 Method for regulation of expression of low-density lipoprotein receptor, and enhancer of expression of low-density lipoprotein receptor |
| 09/11/2009 | WO2009109654A2 Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1 |
| 09/11/2009 | WO2009109616A2 Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109610A1 Use of nad information inhibitors for the treatment of ischemia-reperfusion injury |
| 09/11/2009 | WO2009109573A1 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases |
| 09/11/2009 | WO2009109549A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 09/11/2009 | WO2009109132A1 A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases |
| 09/11/2009 | WO2009061889A4 Grape polyphenolics for platelet and bacterial control |
| 09/11/2009 | WO2009047826A3 Pharmaceutical composition comprising sucralphate and mesalazine |
| 09/11/2009 | WO2009040069A3 Use of bq-610 alone or in combination with helodermin as a therapeutic agent |
| 09/11/2009 | WO2009033821A3 Use of a peptide as a therapeutic agent |
| 09/11/2009 | WO2009033779A3 Nociceptin for use as a therapeutic agent |
| 09/11/2009 | WO2009033778A3 Mage-3 antigen and others for use as a therapeutic agent |
| 09/11/2009 | WO2009033775A3 Peptide alpmhir alone or in combination with peptide yvpfppf as therapeutic agent |
| 09/11/2009 | WO2009033732A3 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent |
| 09/11/2009 | WO2009033729A3 Therapeutic uses of gastrin- 1 and g- pen-grgdspca |
| 09/11/2009 | WO2009033683A3 Galanin message associated peptide alone or in combination with minigastrin as a therapeutic agent |
| 09/11/2009 | WO2008150308A3 Bcl-2 proteins for inhibiting cell death or inflammation in mammals |
| 09/11/2009 | WO2008120085A3 Angiogenic composition |
| 09/11/2009 | CA2717013A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 09/11/2009 | CA2717012A1 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases |
| 09/11/2009 | CA2716352A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 09/11/2009 | CA2715065A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1 |
| 09/11/2009 | CA2714436A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227809 New 2-(alpha-hydroxypentyl) benzoates, their preparations and their uses |
| 09/10/2009 | US20090227671 Prevention and treatment of atherosclerosis with lithospermate B |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227646 Compositions Comprising Nebivolol |
| 09/10/2009 | US20090227643 3-benzyloxycarbonylmethyl-4,5-dimethyl-thiazole-3-bromide, used for improving skin elasticity or reducing wrinkles, treating diabetes, kidney damage, hypertension, vision defects, neuropathy, osteoarthritis or in teeth antisoilants and preservatives |
| 09/10/2009 | US20090227639 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/10/2009 | US20090227638 Novel Pharmaceutical Compounds |
| 09/10/2009 | US20090227610 Novel triglyceride reducing agent |
| 09/10/2009 | US20090227597 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |
| 09/10/2009 | US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 09/10/2009 | US20090227586 2-anilino-4-(heterocyclic)amino-pyrimidines |
| 09/10/2009 | US20090227560 Substituted imidazole compound and use thereof |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227495 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226524 Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine |
| 09/10/2009 | US20090226519 Hydrogel bioscaffoldings and biomedical device coatings |
| 09/10/2009 | US20090226518 (monitoring only) combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hypelipidemia once a day at night |
| 09/10/2009 | US20090226516 Sartan compositions |
| 09/10/2009 | US20090226513 Na/K-ATpase Ligand |
| 09/10/2009 | US20090226512 Methods and Compositions for Oral Delivery of FTS |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226454 Antibodies against a peptide epitope of apoliporotein b |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/10/2009 | US20090226427 Novel pharmaceutical compositions for modulating angiogenesis |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226420 Methods of Determining the Risk of Developing Coronary Artery Disease |
| 09/10/2009 | US20090226413 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226410 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 09/10/2009 | US20090226402 Compositions and Methods of Vascular Injury Repair |
| 09/10/2009 | US20090226377 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 09/10/2009 | US20090226375 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF |
| 09/10/2009 | US20090226369 STQ Peptides |
| 09/10/2009 | US20090226368 Androgen-Receptor (AR) Ligands for Use in the Treatment and Diagnosis of AR-Related Pathologies |
| 09/10/2009 | DE102008012909A1 Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen Use of flavonoid compounds for the prophylaxis and treatment of ischemic or inflammatory cardiovascular diseases |
| 09/09/2009 | EP2098515A1 Substituted carbinol compound |
| 09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP2098509A1 1-naphthyl alkylpiperidine derivative |
| 09/09/2009 | EP2098231A1 Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury |
| 09/09/2009 | EP2098230A1 Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis |
| 09/09/2009 | EP2098229A1 Nerve regeneration agent |
| 09/09/2009 | EP2098226A1 AKAP-PKA interaction inhibitors for use in the treatment of heart diseases |
| 09/09/2009 | EP2098222A1 Physiologically active substance-containing granular composition and method of producing the same |
| 09/09/2009 | EP2097404A1 Substituted dipyridyl-dihydropyrazolones and use thereof |
| 09/09/2009 | EP2097391A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 09/09/2009 | EP2097379A1 Carboxamide derivatives as ion channel modulators |
| 09/09/2009 | EP2097378A1 Novel seh inhibitors and their use |
| 09/09/2009 | EP2097377A1 Renin inhibitors |
| 09/09/2009 | EP2097376A2 Spiro-piperidine derivatives |